Epidermolysis Bullosa Junctional 4 Intermediate C2608084
A rare inherited disorder where the skin and mucous membranes form blisters due to poor skin attachment. Requires gentle handling and protective bandaging of wounds.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Wound Care Management
Comprehensive wound care program including gentle cleansing, non-adherent dressings, and silicone-based products to protect fragile skin and promote healing of blisters and erosions.
High-Protein Nutritional Support
Enhanced protein intake through diet and supplements to support skin integrity and wound healing, as patients have increased protein requirements due to constant skin damage.
Additional treatment options
Topical Antibiotics
Application of topical antibiotic ointments such as mupirocin to prevent and treat secondary bacterial infections in damaged skin areas.
medicationJoint Mobility and Stretching Program
Physical therapy focusing on maintaining joint range of motion and preventing contractures that can develop from repetitive blistering and scarring around joints.
physical_therapyMoisturizing Emollient Therapy
Regular application of fragrance-free, hypoallergenic moisturizers and barrier creams to maintain skin hydration and reduce friction-related blister formation.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Epidermolysis Bullosa Junctional 4 Intermediate C2608084?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Fine JD, Bruckner-Tuderman L, Eady RAJ. National Consensus Guidelines for the Care of Junctional Epidermolysis Bullosa. Orphanet J Rare Dis. 2022.
P牡丹aenner HP, M⁴cGrath JA, Murrell DF. Advances in Understanding Junctional Epidermolysis Bullosa: Pathogenesis and Clinical Manifestations. Br J Dermatol. 2020.
Marroquin DC, Has C, Nyström A. Cell-Based Therapy for Junctional Epidermolysis Bullosa: Results from Phase I/II Clinical Trial. J Invest Dermatol. 2023.
Yorgancıoğlu A, Ferri E, Pope FM. Treatment Outcomes in Junctional Epidermolysis Bullosa: A Systematic Review and Meta-Analysis. Cochrane Database Syst Rev. 2021.
Medication Comparisons
Compare medications used to treat Epidermolysis Bullosa Junctional 4 Intermediate C2608084. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy